Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England

JAMA. 2014 Dec;312(24):2684-6. doi: 10.1001/jama.2014.14484.

Authors

Chang-Fu Kuo¹, Matthew J Grainge², Christian Mallen³, Weiya Zhang⁴, Michael Doherty⁴

Affiliations

¹ Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
² Division of Epidemiology and Public Health, University of Nottingham, Nottingham, England.
³ Arthritis Research UK Primary Care Centre, Keele University, Keele, England.
⁴ Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England.

PMID: 25536262
DOI: 10.1001/jama.2014.14484

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

England
Female
Gout / drug therapy*
Gout Suppressants / therapeutic use*
Guideline Adherence*
Humans
Male
Middle Aged
Practice Patterns, Physicians' / statistics & numerical data*
Uric Acid / metabolism

Substances

Gout Suppressants
Uric Acid

Grants and funding